Research ArticleBasic Science Investigation
Radiation Dose to the Testes after 131I Therapy for Ablation of Postsurgical Thyroid Remnants in Patients with Differentiated Thyroid Cancer
Claudia Ceccarelli, Paolo Battisti, Maurizio Gasperi, Elena Fantuzzi, Furio Pacini, Gianfranco Gualdrini, Maria Cristina Pierantoni, Andrea Luciani, Darije Djokich and Aldo Pinchera
Journal of Nuclear Medicine October 1999, 40 (10) 1716-1721;
Claudia Ceccarelli
Paolo Battisti
Maurizio Gasperi
Elena Fantuzzi
Furio Pacini
Gianfranco Gualdrini
Maria Cristina Pierantoni
Andrea Luciani
Darije Djokich


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radiation Dose to the Testes after 131I Therapy for Ablation of Postsurgical Thyroid Remnants in Patients with Differentiated Thyroid Cancer
Claudia Ceccarelli, Paolo Battisti, Maurizio Gasperi, Elena Fantuzzi, Furio Pacini, Gianfranco Gualdrini, Maria Cristina Pierantoni, Andrea Luciani, Darije Djokich, Aldo Pinchera
Journal of Nuclear Medicine Oct 1999, 40 (10) 1716-1721;
Radiation Dose to the Testes after 131I Therapy for Ablation of Postsurgical Thyroid Remnants in Patients with Differentiated Thyroid Cancer
Claudia Ceccarelli, Paolo Battisti, Maurizio Gasperi, Elena Fantuzzi, Furio Pacini, Gianfranco Gualdrini, Maria Cristina Pierantoni, Andrea Luciani, Darije Djokich, Aldo Pinchera
Journal of Nuclear Medicine Oct 1999, 40 (10) 1716-1721;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report